Dr. Jaffee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 N Wolfe St
Baltimore, MD 21287Phone+1 410-955-8964
Education & Training
- Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1989 - 1992
- UPMC Medical EducationInternship, Internal Medicine, 1985 - 1986
- New York Medical CollegeClass of 1985
Certifications & Licensure
- MD State Medical License 1989 - 2026
- PA State Medical License 1986 - 1990
- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Palliative Stereotactic Radiation for Pancreatic or Periampullary Adenocarcinoma Start of enrollment: 2013 Jan 01
Publications & Presentations
PubMed
- Phase 1 Study of Adjuvant Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor-Transduced Pancreatic Tumor Cell Vaccine, Low-Dose Cyclophosphamide, and Stereota...Colin S Hill, Rose Parkinson, Elizabeth M Jaffee, Elizabeth Sugar, Lei Zheng
International Journal of Radiation Oncology, Biology, Physics. 2025-03-15 - Author Correction: Stromal changes in the aged lung induce an emergence from melanoma dormancy.Mitchell E Fane, Yash Chhabra, Gretchen M Alicea, Devon A Maranto, Stephen M Douglass
Nature. 2025-02-01 - Pan-tumor analysis to investigate the obesity paradox in immune checkpoint blockade.Stephanie L Alden, Soren Charmsaz, Howard L Li, Hua-Ling Tsai, Ludmila Danilova
Journal for Immunotherapy of Cancer. 2025-01-19
Journal Articles
- Development of Tumor Mutation Burden as an Immunotherapy Biomarker: Utility for the Oncology ClinicMark Yarchoan, Elizabeth Jaffee, Annals of Oncology
Press Mentions
- Drug Combination Prompts Immune Response in Some Resistant Pancreatic CancersNovember 15th, 2024
- Drug Combination Boosts Immune Response in Resistant Pancreatic CancersNovember 15th, 2024
- Drug Combination Prompts Immune Response in Some Resistant Pancreatic CancersNovember 14th, 2024
- Join now to see all
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/elizabeth-jaffee
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: